Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.
Also called NCT05500937
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 1,000 participants
- Registry
-
NCT05500937
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05500937. Randomized; triple masking; primary purpose treatment. Start 2021-03-01 (actual); primary completion 2023-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin
- Condition
- Diabetes Mellitus
- Intervention (Drug)
- UDCA
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
Record details
- Record id
cardio:ct-nct05500937- Content hash
042d7ef183a68a81faf51d55e043835092ed9eaff1b334ebcbd485f70a398902